Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06984588 |
| Consolidated Lead Sponsor | TJ Biopharma Co |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II/III |
| Overall Recruitment Status | ACTIVE NOT RECRUITING |
| Registered Enrollment | 450 participants (ESTIMATED) |
| Registered Start Date | 2024-03-28 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| The Third Xiangya Hospital of Central South University | Changsha, China | Open Hospital Dossier -> |
| Xiangya Hospital of Central South University | Changsha, China | Open Hospital Dossier -> |
| Chongqing University Cancer Hospital | Chongqing, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.